Location: Mountain View, CA
CIK: 0001652044 · Show all filings
Period: Q3 2022 (← Previous) (Next →)
Filing Date: Nov 15, 2022
Total Value: $1.958B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Verve Therapeutics Inc | 10,974,011 | $377M | 19.2% | $60.25 | — | COM | 92539P101 |
| — | EQRX Inc | 47,552,687 | $235M | 12.0% | $6.82 | — | COM | 26886C107 |
| PATH | UiPath Inc | 14,068,674 | $177M | 9.1% | $73.33 | -76.1% | CL A | 90364P105 |
| PL | Planet Labs PBC | 31,942,641 | $173M | 8.9% | $9.47 | -41.7% | COM CL A | 72703X106 |
| DXCM | Dexcom Inc | 2,000,000 | $161M | 8.2% | $85.03 | -0.4% | COM | 252131107 |
| OSCR | Oscar Health Inc | 24,042,864 | $120M | 6.1% | $31.30 | -81.4% | CL A | 687793109 |
| SNOW | Snowflake Inc | 535,604 | $91.03M | 4.6% | $258.49 | -35.9% | CL A | 833445109 |
| LYFT | Lyft Inc | 6,138,154 | $80.84M | 4.1% | $78.29 | -80.3% | CL A COM | 55087P104 |
| DUOL | Duolingo Inc. | 704,444 | $67.08M | 3.4% | $108.48 | -10.3% | CL A COM | 26603R106 |
| FRSH | Freshworks Inc | 4,035,595 | $52.34M | 2.7% | $36.28 | -61.0% | CLASS A COM | 358054104 |
| HOOD | Robinhood Mkts Inc | 4,928,535 | $49.78M | 2.5% | $45.49 | -78.9% | COM CL A | 770700102 |
| — | Lyell Immunopharma Inc. | 5,865,125 | $42.99M | 2.2% | $16.24 | — | COM | 55083R104 |
| — | Benson Hill Inc. | 15,352,271 | $42.06M | 2.1% | $6.98 | — | COMMON STOCK | 082490103 |
| RLAY | Relay Therapeutics Inc | 1,568,753 | $35.09M | 1.8% | $37.40 | -41.3% | COM | 75943R102 |
| GTLB | Gitlab Inc. | 593,404 | $30.39M | 1.6% | $46.51 | +25.5% | CLASS A COM | 37637K108 |
| — | Desktop Metal Inc. | 11,048,730 | $28.62M | 1.5% | $17.20 | — | COM CL A | 25058X105 |
| — | Velo3d Inc | 4,900,000 | $19.31M | 1.0% | $1.38 | — | COMMON STOCK | 92259N104 |
| — | 23andMe Holding Co. | 6,736,785 | $19.27M | 1.0% | $6.66 | — | CLASS A COM | 90138Q108 |
| IVVD | Invivyd Inc. | 5,680,785 | $17.78M | 0.9% | $37.11 | -89.2% | COM | 00534A102 |
| SANA | Sana Biotechnology Inc. | 2,812,500 | $16.88M | 0.9% | $32.56 | -77.8% | COM | 799566104 |
| BEAM | Beam Therapeutics Inc. | 321,604 | $15.32M | 0.8% | $21.73 | +162.5% | COM | 07373V105 |
| — | RAPT Therapeutics Inc. | 540,270 | $13M | 0.7% | $27.61 | — | COM | 75382E109 |
| GLUE | Monte Rosa Therapeutics Inc. | 1,464,015 | $11.96M | 0.6% | $20.37 | -54.9% | COM | 61225M102 |
| ILMN | Illumina Inc. | 53,470 | $10.2M | 0.5% | $459.88 | -57.0% | COM | 452327109 |
| RANI | Rani Therapeutics Hldgs Inc. | 714,471 | $6.845M | 0.3% | $16.59 | -36.1% | COM CL A | 753018100 |
| VERA | Vera Therapeutics Inc. | 301,580 | $6.427M | 0.3% | $15.54 | +20.5% | CL A | 92337R101 |
| — | Decibel Therapeutics Inc. | 1,636,258 | $5.661M | 0.3% | $11.36 | — | COM | 24343R106 |
| — | New Relic Inc. | 91,132 | $5.229M | 0.3% | $65.40 | — | COM | 64829B100 |
| — | Science 37 Holdings Inc. | 3,207,260 | $5.164M | 0.3% | $12.47 | — | COM | 808644108 |
| BRNS | Vaccitech PLC | 1,513,644 | $4.844M | 0.2% | $16.78 | — | ADS | 91864C107 |
| — | Kronos Bio Inc. | 1,438,232 | $4.818M | 0.2% | $29.87 | — | COM | 50107A104 |
| — | Magenta Therapeutics Inc. | 3,339,138 | $4.708M | 0.2% | $13.50 | — | COM | 55910K108 |
| FHTX | Foghorn Therapeutics Inc. | 500,901 | $4.298M | 0.2% | $19.16 | -32.8% | COM | 344174107 |
| TCRX | Tscan Therapeutics Inc. | 1,077,080 | $3.285M | 0.2% | $9.27 | -64.7% | COM | 89854M101 |
| AMPL | Amplitude Inc | 189,447 | $2.931M | 0.1% | $54.38 | -70.5% | COM CL A | 03213A104 |
| TNYA | Tenaya Therapeutics Inc. | 915,705 | $2.656M | 0.1% | $21.49 | -78.3% | COM | 87990A106 |
| — | Evelo Biosciences Inc. | 1,060,495 | $2.216M | 0.1% | $11.80 | — | COM | 299734103 |
| FULC | Fulcrum Therapeutics Inc | 255,452 | $2.066M | 0.1% | $11.14 | -35.8% | COM | 359616109 |
| SPRO | Spero Therapeutics Inc. | 889,979 | $1.78M | 0.1% | $12.27 | -91.9% | COM | 84833T103 |
| ALEC | Alector Inc. | 175,866 | $1.664M | 0.1% | $18.92 | -42.8% | COM | 014442107 |
| AUTL | Autolus Therapeutics PLC | 698,262 | $1.494M | 0.1% | $26.79 | — | SPON ADR | 05280R100 |
| TSHA | Taysha Gene Therapies Inc. | 640,882 | $1.237M | 0.1% | $23.52 | -84.6% | COM SHS | 877619106 |
| EXAS | Exact Sciences Corp | 23,205 | $754K | 0.0% | $105.58 | -61.0% | COM | 30063P105 |
| HYPR | Hyperfine Inc. | 898,720 | $728K | 0.0% | $9.78 | -85.6% | COM CL A | 44916K106 |
| — | Invitae Corp | 215,965 | $529K | 0.0% | $28.43 | — | COM | 46185L103 |
| OPRT | Oportun Finl Corp | 94,788 | $414K | 0.0% | $23.37 | -69.6% | COM | 68376D104 |
| QNCX | Quince Therapeutics Inc | 189,122 | $252K | 0.0% | $29.87 | -93.6% | COM | 22053A107 |
| HLTHQ | Cue Health Inc | 27,000 | $81,000 | 0.0% | $6.44 | — | COM | 229790100 |
| RGEN | Repligen Corp | 383 | $72,000 | 0.0% | $269.41 | -21.7% | COM | 759916109 |